| TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ... Science translational medicine 6 (243), 243ra86-243ra86, 2014 | 731 | 2014 |
| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 448 | 2016 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 397 | 2013 |
| A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats J van der Zee, I Gijselinck, L Dillen, T Van Langenhove, J Theuns, ... Human mutation 34 (2), 363-373, 2013 | 315 | 2013 |
| Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease P Podlesniy, J Figueiro‐Silva, A Llado, A Antonell, R Sanchez‐Valle, ... Annals of neurology 74 (5), 655-668, 2013 | 208 | 2013 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 172 | 2021 |
| Partial 7q11. 23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams–Beuren syndrome neurocognitive profile A Antonell, M Del Campo, LF Magano, L Kaufmann, JM De La Iglesia, ... Journal of medical genetics 47 (5), 312-320, 2010 | 163 | 2010 |
| Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease M Balasa, E Gelpi, A Antonell, MJ Rey, R Sanchez-Valle, JL Molinuevo, ... Neurology 76 (20), 1720-1725, 2011 | 159 | 2011 |
| Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease T Botta‐Orfila, X Morató, Y Compta, JJ Lozano, N Falgas, F Valldeoriola, ... Journal of neuroscience research 92 (8), 1071-1077, 2014 | 157 | 2014 |
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study EL van der Ende, LH Meeter, JM Poos, JL Panman, LC Jiskoot, ... The Lancet Neurology 18 (12), 1103-1111, 2019 | 156 | 2019 |
| Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ... Human molecular genetics 23 (3), 749-754, 2014 | 144 | 2014 |
| TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions MD Gallagher, E Suh, M Grossman, L Elman, L McCluskey, ... Acta neuropathologica 127, 407-418, 2014 | 142 | 2014 |
| CSF biomarkers for the differential diagnosis of Alzheimer's disease: a large-scale international multicenter study M Ewers, N Mattsson, L Minthon, JL Molinuevo, A Antonell, J Popp, ... Alzheimer's & Dementia 11 (11), 1306-1315, 2015 | 138 | 2015 |
| Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer’s disease: potential and limitations M Cosín-Tomás, A Antonell, A Lladó, D Alcolea, J Fortea, M Ezquerra, ... Molecular neurobiology 54, 5550-5562, 2017 | 135 | 2017 |
| Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension M Del Campo, A Antonell, LF Magano, FJ Muñoz, R Flores, M Bayés, ... The American Journal of Human Genetics 78 (4), 533-542, 2006 | 133 | 2006 |
| Assessing the role of the TREM2 p. R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia A Ruiz, O Dols-Icardo, MJ Bullido, P Pastor, E Rodríguez-Rodríguez, ... Neurobiology of aging 35 (2), 444. e1-444. e4, 2014 | 131 | 2014 |
| Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease A Antonell, A Mansilla, L Rami, A Lladó, A Iranzo, J Olives, M Balasa, ... Journal of Alzheimer's Disease 42 (3), 901-908, 2014 | 127 | 2014 |
| A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease A Antonell, A Lladó, J Altirriba, T Botta-Orfila, M Balasa, M Fernández, ... Neurobiology of aging 34 (7), 1772-1778, 2013 | 117 | 2013 |
| Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study C Pottier, X Zhou, RB Perkerson, M Baker, GD Jenkins, DJ Serie, ... The Lancet Neurology 17 (6), 548-558, 2018 | 113 | 2018 |
| Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas J Fortea, R Sala-Llonch, D Bartrés-Faz, A Lladó, C Solé-Padullés, ... Biological psychiatry 70 (2), 183-190, 2011 | 111 | 2011 |
